Evan Smith
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Alkaloids: synthesis and pharmacology 2
- Inflammatory mediators and NSAID effects 2
- Treatment of Major Depression 2
-
- Eicosanoids and Hypertension Pharmacology 2
- Co-authors
- Deepak Dalvie (5 shared papers)Ping Kang (4 shared papers)Cho‐Ming Loi (2 shared papers)Alan J. Deese (3 shared papers)Haig P. Bozigian (4 shared papers)Ajay Madan (2 shared papers)Dimitri E. Grigoriadis (2 shared papers)Sam R.J. Hoare (1 shared paper)
- Journals
- Drug Metabolism and Disposition (4 papers)Neurology (3 papers)Chemical Research in Toxicology (2 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Evan Smith
14 papers receiving 502 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 262
- Biochemistry 91
- Pharmacology 66
- Oncology 89
- Pharmaceutical Science 19
Countries citing papers authored by Evan Smith
This map shows the geographic impact of Evan Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Smith more than expected).
Fields of papers citing papers by Evan Smith
This network shows the impact of papers produced by Evan Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Smith. The network helps show where Evan Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 151 | |
| 2 | 2012 | 83 | |
| 3 | 2017 | 78 | |
| 4 | 2008 | 49 | |
| 5 | 2008 | 41 | |
| 6 | 2013 | 38 | |
| 7 | 2007 | 35 | |
| 8 | Pharmacokinetics of monoamine oxidase inhibitors. | 1991 | 27 |
| 9 | 2006 | 18 | |
| 10 | 2012 | 3 | |
| 11 | 1988 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 1 |
About Evan Smith
Evan Smith is a scholar working on Pharmacology, Pharmacology, Biochemistry, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 14 papers that have together received 527 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Alkaloids: synthesis and pharmacology (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Chemical synthesis and alkaloids (2 papers), Inflammatory mediators and NSAID effects (2 papers), Treatment of Major Depression (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Pharmacology (262 citations), Biochemistry (91 citations), Pharmacology (66 citations), Oncology (89 citations) and Pharmaceutical Science (19 citations). Evan Smith has collaborated with scholars based in United States. Frequent co-authors include Deepak Dalvie, Ping Kang, Cho‐Ming Loi, Alan J. Deese, Haig P. Bozigian, Ajay Madan, Dimitri E. Grigoriadis, Sam R.J. Hoare, Dennis A. Smith and Susan I. Hurst. Their work appears in journals such as Drug Metabolism and Disposition, Neurology, Chemical Research in Toxicology, Bioorganic & Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.